{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "currency": "EUR", "market": "dr_market", "esgPopulated": false, "gmtOffSetMilliseconds": 7200000, "exchange": "FRA", "longName": "Harpoon Therapeutics, Inc.", "shortName": "HARPOON THERAPEUTICS", "regularMarketPrice": 0.74, "regularMarketChangePercent": 2.777775, "messageBoardId": "finmb_413195889", "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.719697, "fiftyTwoWeekLow": 0.486, "fiftyTwoWeekHigh": 2.64, "earningsTimestamp": 1683837000, "earningsTimestampStart": 1691492340, "earningsTimestampEnd": 1692014400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "fiftyTwoWeekLowChange": 0.254, "fiftyTwoWeekLowChangePercent": 0.52263373, "fiftyTwoWeekRange": "0.486 - 2.64", "fiftyTwoWeekHighChange": -1.9000001, "epsTrailingTwelveMonths": -2.2, "epsForward": -2.21, "epsCurrentYear": -3.58, "priceEpsCurrentYear": -0.20670392, "sharesOutstanding": 37595800, "bookValue": 0.151, "fiftyDayAverage": 0.62612, "fiftyDayAverageChange": 0.11388004, "fiftyDayAverageChangePercent": 0.18188214, "twoHundredDayAverage": 1.019705, "twoHundredDayAverageChange": -0.27970505, "twoHundredDayAverageChangePercent": -0.27429995, "marketCap": 27820892, "forwardPE": -0.33484164, "priceToBook": 4.9006624, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.7 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1550041200000, "priceHint": 4, "regularMarketChange": 0.01999998, "regularMarketTime": 1683875702, "regularMarketDayHigh": 0.74, "regularMarketDayRange": "0.74 - 0.74", "regularMarketDayLow": 0.74, "regularMarketVolume": 400, "regularMarketPreviousClose": 0.72, "bid": 0.71, "ask": 0.74, "bidSize": 0, "askSize": 0, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 0.74, "averageDailyVolume3Month": 6, "averageDailyVolume10Day": 0, "symbol": "5HT.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "131 Oyster Point Boulevard", "address2": "Suite 300", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 443 7400", "website": "https://www.harpoontx.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candidate, including HPN328, which is in Phase I/II clinical trials for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-expressing tumors; and HPN217 that is in Phase I clinical trials for the treatment of multiple myeloma. Its preclinical stage product is HPN601 for the treatment of multiple solid tumor indications. It has a discovery collaboration and license agreement with AbbVie Biotechnology Ltd. to develop and commercialize products that incorporate its proprietary TriTAC platform technology together with soluble T cell receptors. The company was incorporated in 2015 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 50, "companyOfficers": [{"maxAge": 1, "name": "Ms. Julie M. Eastland M.B.A.", "age": 58, "title": "Pres, CEO, Sec. & Director", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 910774, "fmt": "910.77k", "longFmt": "910,774"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Georgia L. Erbez", "age": 55, "title": "Consultant", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": {"raw": 484898, "fmt": "484.9k", "longFmt": "484,898"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Luke N. Walker M.D.", "age": 50, "title": "Chief Medical Officer", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 424434, "fmt": "424.43k", "longFmt": "424,434"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Chatan  Charan Ph.D.", "title": "Sr. VP of Product Devel., Technical & Manufacturing Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Wendy  Chang", "title": "Sr. VP of HR", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Rachael  Lester", "title": "Sr. VP of Bus. Devel. & Corp. Strategy", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Banmeet  Anand Ph.D.", "title": "Sr. VP of Translational Medicine", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}